382 related articles for article (PubMed ID: 19422736)
1. Hematological indices, mountain sickness and MRI brain abnormalities in professional and amateur mountain climbers after altitude exposure.
Fayed N; Diaz L; Dávila J; Medrano J
Neurol Res; 2010 Mar; 32(2):144-7. PubMed ID: 19422736
[TBL] [Abstract][Full Text] [Related]
2. Evidence of brain damage after high-altitude climbing by means of magnetic resonance imaging.
Fayed N; Modrego PJ; Morales H
Am J Med; 2006 Feb; 119(2):168.e1-6. PubMed ID: 16443427
[TBL] [Abstract][Full Text] [Related]
3. Reduced oxygen due to high-altitude exposure relates to atrophy in motor-function brain areas.
Di Paola M; Bozzali M; Fadda L; Musicco M; Sabatini U; Caltagirone C
Eur J Neurol; 2008 Oct; 15(10):1050-7. PubMed ID: 18717724
[TBL] [Abstract][Full Text] [Related]
4. Prior altitude experience of climbers attempting to summit Aconcagua.
Borm N; Van Roo JD; Pesce C; Courtney DM; Malik S; Lazio MP
High Alt Med Biol; 2011; 12(4):387-91. PubMed ID: 22206564
[TBL] [Abstract][Full Text] [Related]
5. New evidence from magnetic resonance imaging of brain changes after climbs at extreme altitude.
Garrido E; Segura R; Capdevila A; Aldomá J; Rodríguez FA; Javierra C; Ventura JL
Eur J Appl Physiol Occup Physiol; 1995; 70(6):477-81. PubMed ID: 7556118
[TBL] [Abstract][Full Text] [Related]
6. Cortical atrophy and other brain magnetic resonance imaging (MRI) changes after extremely high-altitude climbs without oxygen.
Garrido E; Castelló A; Ventura JL; Capdevila A; Rodríguez FA
Int J Sports Med; 1993 May; 14(4):232-4. PubMed ID: 8325724
[TBL] [Abstract][Full Text] [Related]
7. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m.
Bloch KE; Turk AJ; Maggiorini M; Hess T; Merz T; Bosch MM; Barthelmes D; Hefti U; Pichler J; Senn O; Schoch OD
High Alt Med Biol; 2009; 10(1):25-32. PubMed ID: 19326598
[TBL] [Abstract][Full Text] [Related]
8. Morphological Brain Changes after Climbing to Extreme Altitudes--A Prospective Cohort Study.
Kottke R; Pichler Hefti J; Rummel C; Hauf M; Hefti U; Merz TM
PLoS One; 2015; 10(10):e0141097. PubMed ID: 26509635
[TBL] [Abstract][Full Text] [Related]
9. Medication Use Among Mount Everest Climbers: Practice and Attitudes.
Luks AM; Grissom C; Freer L; Hackett P
High Alt Med Biol; 2016 Dec; 17(4):315-322. PubMed ID: 27763796
[TBL] [Abstract][Full Text] [Related]
10. High altitude pulmonary edema in mountain climbers.
Korzeniewski K; Nitsch-Osuch A; Guzek A; Juszczak D
Respir Physiol Neurobiol; 2015 Apr; 209():33-8. PubMed ID: 25291181
[TBL] [Abstract][Full Text] [Related]
11. Brain magnetic resonance imaging (MRI) and neurological changes after a single high altitude climb.
Anooshiravani M; Dumont L; Mardirosoff C; Soto-Debeuf G; Delavelle J
Med Sci Sports Exerc; 1999 Jul; 31(7):969-72. PubMed ID: 10416557
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological functioning after prolonged high altitude exposure in mountaineering.
Clark CF; Heaton RK; Wiens AN
Aviat Space Environ Med; 1983 Mar; 54(3):202-7. PubMed ID: 6847554
[TBL] [Abstract][Full Text] [Related]
13. Cognitive changes at high altitude in healthy climbers and in climbers developing acute mountain sickness.
Regard M; Landis T; Casey J; Maggiorini M; Bärtsch P; Oelz O
Aviat Space Environ Med; 1991 Apr; 62(4):291-5. PubMed ID: 2031628
[TBL] [Abstract][Full Text] [Related]
14. Are Himalayan Sherpas better protected against brain damage associated with extreme altitude climbs?
Garrido E; Segura R; Capdevila A; Pujol J; Javierre C; Ventura JL
Clin Sci (Lond); 1996 Jan; 90(1):81-5. PubMed ID: 8697710
[TBL] [Abstract][Full Text] [Related]
15. Heart rate variability during two sequential mountaineering expeditions.
Tryliskyy Y
Travel Med Infect Dis; 2011 May; 9(3):165-8. PubMed ID: 21602105
[TBL] [Abstract][Full Text] [Related]
16. Colour vision at very high altitude.
Leid J; Campagne JM
Color Res Appl; 2001; 26 Suppl 1():S281-3. PubMed ID: 12269339
[TBL] [Abstract][Full Text] [Related]
17. Use of a hypobaric chamber for pre-acclimatization before climbing Mount Everest.
Richalet JP; Bittel J; Herry JP; Savourey G; Le Trong JL; Auvert JF; Janin C
Int J Sports Med; 1992 Oct; 13 Suppl 1():S216-20. PubMed ID: 1483780
[TBL] [Abstract][Full Text] [Related]
18. Mountaineering fatalities on Aconcagua: 2001-2012.
Westensee J; Rogé I; Van Roo JD; Pesce C; Batzli S; Courtney DM; Lazio MP
High Alt Med Biol; 2013 Sep; 14(3):298-303. PubMed ID: 24028641
[TBL] [Abstract][Full Text] [Related]
19. Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude.
Droma Y; Hanaoka M; Basnyat B; Arjyal A; Neupane P; Pandit A; Sharma D; Kubo K
High Alt Med Biol; 2006; 7(4):312-4. PubMed ID: 17173517
[TBL] [Abstract][Full Text] [Related]
20. [Mountaineering and altitude sickness].
Maggiorini M
Ther Umsch; 2001 Jun; 58(6):387-93. PubMed ID: 11441701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
